Affiliation:
1. Centre of Excellence for Pharmaceutical Sciences North‐West University Potchefstroom South Africa
2. Laboratory of Microbiology, Parasitology and Hygiene, Infla‐Med Centre of Excellence University of Antwerp Antwerp Belgium
Abstract
AbstractTrypanosomes and Leishmania are parasitic protozoans that affect millions of people globally. Herein we report the synthesis of 2‐aroyl quinazolinones and their antiprotozoal efficacy against Trypanosoma brucei, Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania infantum. These compounds were counter‐screened against a human cell line for cytotoxicity. Thirteen of the twenty target compounds in this study inhibited the growth of these parasites, with compounds KJ1, and KJ10 exhibiting IC50 values of 4.7 μM (T. b. brucei) and 1.1 μM (T. b. rhodesiense), respectively.
Funder
National Research Foundation
Subject
Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献